Hideaki Mabashi-Asazuma, Donald L. Jarvis. A new insect cell line engineered to produce recombinant glycoproteins with cleavable N-glycans. Journal of Biological Chemistry. 2021. 101454-101454
Motohiro Nonaka, Hideaki Mabashi-Asazuma, Donald L. Jarvis, Kazuhiko Yamasaki, Tomoya O. Akama, Masato Nagaoka, Toshio Sasai, Itsuko Kimura-Takagi, Yoichi Suwa, Takashi Yaegashi, et al. Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides. PLOS ONE. 2021. 16. 1. e0241157
Miori Tanaka, Akari Sato, Yoshimi Kishimoto, Hideaki Mabashi-Asazuma, Kazuo Kondo, Kaoruko Iida. Gallic Acid Inhibits Lipid Accumulation via AMPK Pathway and Suppresses Apoptosis and Macrophage-Mediated Inflammation in Hepatocytes. Nutrients. 2020. 12. 5. 1479-1479
Hideaki Mabashi-Asazuma, Donald L. Jarvis. Knocking-out fdl gene in a baculovirus host insect cell line using new CRISPR-Cas9 tools for lepidopteran insect cell lines. GLYCOBIOLOGY. 2016. 26. 12. 1452-1452
Hideaki Mabashi-Asazuma, Chu-Wei Kuo, Kay-Hooi Khoo, Donald L. Jarvis. Modifying an insect cell N-glycan processing pathway using CRISPR-Cas9 technology. GLYCOBIOLOGY. 2015. 25. 11. 1273-1273
Donald Jarvis, Christoph Geisler, Hideaki Mabashi-Asazuma, Ann Toth. Biomedical engineering: An approach that can be effectively used not only to improve, but also to probe insect protein glycosylation pathways. GLYCOBIOLOGY. 2012. 22. 11. 1580-1581
Hideaki Mabashi-Asazuma, Christoph Geisler, Donald L. Jarvis. Identifying bottlenecks in efforts to glycoengineer insect cells for humanized Nglycan processing. GLYCOBIOLOGY. 2012. 22. 11. 1596-1596